Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaliman

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|September 1, 1986
Prostacyclin synthesis stimulating plasma factor in coronary heart diseaseH Sinzinger, J Kaliman, B A Peskar
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1988
Effect of high and low-dose aspirin on circulating endothelial cellsH Sinzinger, F Rauscha, P Fitscha, et al.
Experimentelle Pathologie|January 1, 1980
Diminished prostacyclin formation in forearm venous tissue of patients with peripheral occlusive arteriopathyH Sinzinger, J Kaliman, K Silberbauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1980
[Platelet sensitivity to prostacyclin in diabetic and nondiabetic patients with atherosclerotic vascular changes: a measure of platelet membrane prostacyclin receptors?]K Klein, J Kaliman, H Sinzinger, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Interaction between the platelet derived growth factor and prostaglandin I2 is important for atherosclerosisH Sinzinger, G Steurer, J Kaliman, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandinsP Fitscha, J Kaliman, J O'Grady, et al.
Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.
The New England Journal of Medicine|October 18, 1984
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandinsH Sinzinger, J O'Grady, P Fitscha, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]H Sinzinger, P Fitscha, F Rauscha, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Prostaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H Sinzinger
Prostaglandins, Leukotrienes, and Medicine|September 1, 1986
Prostacyclin synthesis stimulating plasma factor in coronary heart diseaseH Sinzinger, J Kaliman, B A Peskar
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1988
Effect of high and low-dose aspirin on circulating endothelial cellsH Sinzinger, F Rauscha, P Fitscha, et al.
Experimentelle Pathologie|January 1, 1980
Diminished prostacyclin formation in forearm venous tissue of patients with peripheral occlusive arteriopathyH Sinzinger, J Kaliman, K Silberbauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1980
[Platelet sensitivity to prostacyclin in diabetic and nondiabetic patients with atherosclerotic vascular changes: a measure of platelet membrane prostacyclin receptors?]K Klein, J Kaliman, H Sinzinger, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Interaction between the platelet derived growth factor and prostaglandin I2 is important for atherosclerosisH Sinzinger, G Steurer, J Kaliman, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandinsP Fitscha, J Kaliman, J O'Grady, et al.
Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.
The New England Journal of Medicine|October 18, 1984
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandinsH Sinzinger, J O'Grady, P Fitscha, et al.
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]H Sinzinger, P Fitscha, F Rauscha, et al.
Pageof 10